Brighthouse FinancialBHF

Key highlights

• Merger timeline extended: The company’s $4.1 billion merger with Aquarian Capital is still waiting for regulatory sign-off from Delaware, New York, and Massachusetts, and the deadline to finish has been automatically extended to December 6, 2026. This delay pushes back the date when shareholders will receive the promised $70.00 per share in cash.
• Shield annuity sales growth: Sales of Shield Level annuities reached a record $2.1 billion this quarter, helping drive total annuity sales to $2.4 billion. These products are critical because they are the main engine keeping the business growing while other types of older, fixed annuities saw sales fall.
• Capital levels remain steady: The company’s risk-based capital ratio, a measure used by regulators to ensure insurers can pay their claims, stayed between 430% and 450%. Keeping this number above the 400% minimum target is vital for maintaining the company's financial health during the pending sale.
• Investment income feeling pressure: Investment income yield fell to 4.17% from 4.28% a year ago, mostly because alternative investments like limited partnerships earned less. Since Brighthouse relies on investing customer premiums to make a profit, this lower return makes it harder to grow earnings.
• Outlook for net income: Management expects net income to remain volatile because the company uses hedges, which are like insurance policies against market moves, that do not always perfectly align with accounting rules. While this quarter saw net income of $956 million, it was a massive swing from the $792 million loss reported just three months ago.

Our take: This was a mixed quarter defined by the wait for a buyer. While record Shield sales and solid capital ratios prove the business is still functioning well, the earnings miss shows the pressure of lower investment returns. The case for owning this stock now rests entirely on regulators approving the $70.00 buyout.